Ismael Saibari to Bayern Munich: Bayern confident to close deal next week, medical in USA

Bayern Munich are on the verge of signing highly-rated Moroccan attacking midfielder Ismael Saibari from PSV Eindhoven, with the transfer expected to be finalized next week.

According to transfer expert Fabrizio Romano, Bayern are confident of wrapping up the deal in the coming days. The medical examination will take place in the United States, where Saibari is currently with the Morocco national team for the World Cup.

Deal Status: Agreement with Player Done, Final Touches with PSV Needed

  • Personal terms with Saibari are fully agreed.
  • Negotiations with PSV Eindhoven are advanced, with only final details on the transfer fee and other clauses remaining.
  • Bayern have been working on this move for some time, with Vincent Kompany reportedly a big admirer of the player.

Reports suggest the potential fee could be in the region of €45-60 million, making Saibari one of Bayern’s key summer reinforcements in midfield.

Who is Ismael Saibari?

Born on January 28, 2001, in Terrassa, Spain, the 25-year-old Moroccan international has emerged as one of the standout performers in the Eredivisie.

In the 2025-26 season with PSV, Saibari delivered an impressive 15 goals and 8 assists across competitions, showcasing his creativity, goal-scoring ability, dribbling, and vision from attacking midfield or on the left.

He joined PSV in 2020 and has developed into a key player, earning praise as one of the best young midfielders in Dutch football. Saibari also represents Morocco at international level and is currently in the US preparing for World Cup action.

Why Bayern Munich Want Saibari

Bayern are strengthening their squad under Vincent Kompany after recent departures in midfield. Saibari’s profile — technical ability, goal threat, and work rate — fits perfectly into Bayern’s high-pressing, attacking style. Many fans and analysts see him as a dynamic addition who can contribute immediately or develop into a star at the Allianz Arena.

Comments are closed.